Top Markets
Coin of the day
GridAI Technologies Corp. GridAI Technologies Corp.

GridAI Technologies Corp.

GRDX
Pozycja w akcjach #31212
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical... GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
Cena akcji
$4.13
Kapitalizacja rynkowa
$13.88M
Zmiana (1 dzień)
4.56%
Zmiana (1 rok)
91.20%
Kraj
US
Handel GridAI Technologies Corp. (GRDX)

Kategoria

Historia stopy dywidendy dla GridAI Technologies Corp. (GRDX)
Stopa dywidendy (TTM) dla GridAI Technologies Corp. (symbol akcji: GRDX) na dzień 2026 wynosi: 0
Średnia stopa dywidendy z ostatnich 5 lat: 0.00%
Historia stopy dywidendy dla GridAI Technologies Corp. (GRDX) od 2026 do 2026
Stopa dywidendy na koniec każdego roku (TTM)
Rok Stopa dywidendy Zmień
Za mało danych dla podanych dat.
Stopy dywidendy (TTM) dla podobnych firm lub konkurencji
Firma Stopa dywidendy Kraj
0.00%
US
0.00%
NL
3.12%
AU
0.00%
CH
0.48%
BE